Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROLEX study of paroxetine with telaprevir-based HCV therapy
NL-OMON38871Phase 2Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paroxetine and telaprevir in major depressive disorder (MDD) and hepatitis C virus infection, sponsored by Radboud University Medical Center. Started Sep 2013; status: active, not recruiting.
02
Drugs
paroxetinetelaprevir
03
Conditions
major depressive disorder (MDD)hepatitis C virus infection
Beyond the preview
Go deeper on NL-OMON38871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38871.